Shiva S
ABSTRACT
The use of Nano carriers as drug delivery systems for chemotherapeutical agents will improve the pharmacological properties of normally used medicine in therapy. The clinical success, still because the ease with which surface modifications is created to each liposomes and micelles to accommodate targeting ligands have created these Nano carrier’s especially enticing candidates involving targeted drug delivery. Though not targeted, there is a unit clinically approved liposomal-based medicine that area unit presently wont to treat numerous forms of cancers. This review discusses the employment of liposomes and micelles in cancer medical aid and makes an attempt to produce some current info concerning the clinical standing of many of those Nano carrier-based medicines. Additionally, recent work involving the incorporation of targeting ligands to systems like these so as to enhance co-localization between the drug and cancer cells is additionally self-addressed. What is more, whereas the employment of those Nano carriers especially is that the primary focus here, this review additionally contains a discussion on different normally used Nano carriers in cancer medical aid to incorporate various polymerbased and polymer-protein conjugates. Finally, the likelihood of mistreatment combinatorial approaches involving multiple surface modifications created to each liposome and micelles so as to additional improve their drug delivery capabilities is additionally mentioned.